<DOC>
	<DOC>NCT00092131</DOC>
	<brief_summary>The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.</brief_summary>
	<brief_title>Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)</brief_title>
	<detailed_description />
	<mesh_term>Bronchial Spasm</mesh_term>
	<mesh_term>Asthma, Exercise-Induced</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Participants with mildtomoderate asthma Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>